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tery disease (CAD).
METHODS Content of signal-joint T cells receptor excision circles (sj-
TREC) in T lymphocytes, a molecular marker of RTEs, were assessed
among CAD patients and age-matched controls. Monochrome multi-
plex quantitative PCR method was used to assess samples’ telomere
length, a known indicator of increased cell division. Neutrophils to
lymphocytes ratio (NLR) was calculated to reﬂect the severity of in-
ﬂammatory status. Patients were grouped according to Gensini score
(GS) tertile (low GS<18; intermediate GS 18-41, high GS >41). Predic-
tive value of sj-TREC for disease status was evaluated according to
ordinary logistic regression models.
RESULTS Average copy numbers of sj-TREC per 106 T lymphocytes
among patients with non-ST-elevation acute coronary syndrome
(NSTACS), stable angina (SA) and controls were 877494, 1222539
and 1803 817, respectively (P<0.001). No signiﬁcant difference of
telomere length was found among three groups. NLR was signiﬁ-
cantly higher in NSTACS patients (3.92.9) than SA patients (2.41.1,
P<0.01) and controls (2.10.9, P<0.001). Negative correlation be-
tween sj-TREC and NLR was uncovered (R¼-0.3312, P<0.0001). Sj-
TREC level between SA and NSTACS patients was signiﬁcantly
different in the 50-64 years cohort (P<0.001), but not in the 65-80
cohort. Sj-TREC level showed a negative correlation with age among
healthy controls (R¼-0.5052, p¼0.0005) and SA patients (R¼-0.5158,
p¼0.005), but not NSTACS patients (R¼-0.1415, P¼0.0991). Content of
sj-TREC in high GS group (GS>41) was most signiﬁcantly reduced than
low GS group (GS <18) (P<0.001). Ordinal logistic regression analysis
revealed that higher sj-TREC level was independently associated with
absence of CAD (OR¼0.35, P<0.001) and low Gensini score (OR¼0.21,
P<0.001).
CONCLUSIONS Signiﬁcantly reduced sj-TREC level in SA and NSTACS
patients mainly resulted from decreased thymic output rather than
increased T cell proliferation. Patients with more sever inﬂammatory
status had lower RTEs of T cells. Content of sj-TREC could be inﬂu-
enced both by age and CAD status. Sj-TREC level from elderly patients
was too low to notice a signiﬁcant difference between SA and NSTACS
patients. Unlike the case with controls and SA patients, content of sj-
TREC was so low in NSTACS patients that it appeared no longer
signiﬁcantly related to age among them. Patients with higher GS had
more complicated plaques and might have poorer thymic function.
Ordinal logistic regression analysis demonstrated that higher sj-TREC
level was an independent protective factor to CAD status. In conclu-
sion, accelerated thymic involution may be partly responsible for the
development of CAD via the alteration of equilibrium of peripheral T
cells compartments and interruption of maintained immune toler-
ance.
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Allocrytopine attenuates cardiac transmural dispersion of repolarization
and protects ischemia reperfusion induced arrhythmias in rabbits
Yicheng Fu, Ying Zhao, Yu Zhang, Zhongqi Cai, Qing Dan, Xi Chen,
Tong Yin, Yang Li
The Division of Cardiology, Chinese PLA General Hospital, Beijing,
China
OBJECTIVES Ischemia reperfusion injury is known to impaire cardiac
function in ischemic heart diseases (IHD). Allocryptopine is a botan-
ical alkaloid extracted from Corydalis decumbens (Thunb) Pers Papa-
veraceae. Lately great attention has been paid to its anti-arrhythmic
effects. We hypothesized that allocryptopine can provide protection
against ischemia reperfusion (I/R) injury though reducing transmural
heterogeneity of repolarization in rabbit heart.
METHODS The LADs ligation were conducted to block the blood ﬂow
and reperfuse the myocardium of 48 allocryptopine pretreatment
rabbits. Body-surface electrocardiograms and monophasic action po-
tential (MAP) were recorded before and after acute ischemia and
reperfusion. Transmembrane action potential durations from epicar-
dium, midcardium and endocardium were simultaneously recorded
together with the occurrence of triggered activities and malignant
ventricular arrhythmias.
RESULTS The acute ischemia and subsequent reperfusion shortened
the monophasic actin potential duration (MAPD) of epicardium,
midcardium and endocardium and increased transmural dispersion of
repolarization (TDR) in operation alone group. Treatment of alloc-
ryptopine preferentially prolonged the MAPD50 and MAPD90 of
epicardium and endocardium rather than midcardium, thereby reducethe TDR of ischemia/reperfusion myocardium from 52.38.7 ms/
69.08.0 ms to 30.55.0 ms/ 33.07.0 ms (P ¼0.002). Nine rabbits
were observed early-afterdepolarizations (EADs) and thirteen rabbits
were experienced frequent ventricular tachyarrhythmias during LADs
ligation. Allocryptopine intervention successfully suppressed the I/R-
induced arrhythmias by 35.4% (P ¼0.018).
CONCLUSIONS Allocryptopine maintains the electrophysiological
heterogeneity of repolarization among myocardial layers and effec-
tively prevents I/R induced arrhythmias.
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Clinical effect of recombinant human brain natriuretic peptide combined
with levosimendan on acute myocardial infarction complicated with
heart failure
Zhenda Zheng, Cailian Cheng, Dinghui Liu, Jianrui Zheng,
Zhiming Song, Lin Chen, Xiaoxian Qian
The Third Afﬁliated Hospital, Sun Yat-sen University, Guangzhou
510630, China
OBJECTIVES To observe the efﬁcacy and safety of recombinant hu-
man brain natriuretic peptide (rh-BNP) combined with levosimendan
in treating patients with acute myocardial infarction complicated with
heart failure.
METHODS Hospitalized patients who suffered from anterior wall AMI
with heart failure ( KillipIIwIII ) within 12 to 24 hours from the onset
of chest pain were randomized into two groups (n¼30, respectively):
control group (receiving dobutamine and/or cedilanid on the basis of
essential therapy) and experimental group (receiving rh-BNP com-
bined with levosimendan on the basis of essential therapy). The he-
modynamics, clinical parameters of test and adverse events were
observed before and after treatment.
RESULTS In experimental group, compared with those before treat-
ment, there were statistical differences in respiratory rate (RR), heart
rate (HR), systolic blood pressure (SBP), arterial blood gas oxygen
saturation (SaO2), cardiac index (CI), extravascular lung water index
(EVLWI) at 2h and the following time points after treatment(all
P <0.05). In control group, compared with those before treatment,
there were statistical differences in RR, HR, SaO2, CI, EVLWI at 6h
after treatment and in the next time points (all P <0.05). RR, HR, SBP,
SaO2, CI, EVLWI at 2h and 6h after treatment had statistical differ-
ences between two groups, and the differences in RR, HR, CI, EVLWI
persisted for 72 hours after medicine administration. There was a
statistically signiﬁcant difference between two groups in urine vol-
ume, plasma NT-proBNP concentration, left ventricular ejection
fraction (LVEF) and length of stay in CCU (all P <0.05). For adverse
events monitoring, there was no signiﬁcant change between two
groups in hepatic parameters, electrolyte level and coagulation
function before and after treatment.
CONCLUSIONS rh-BNP combined with Levosimendon is superior to
the conventional drugs in improving hemodynamics, increasing urine
volume, decreasing the plasma NT-proBNP concentration, improving
clinical symptoms, increasing LVEF, and reducing the length of stay in
CCU in patients with acute myocardial infarction complicated with
heart failure, which has better tolerance and safety.GW26-e0268
Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among
Patients After Percutaneous Coronary Intervention
Bo Zheng, Jie Jiang, Yan Zhang, Ronghui Yu, Yong Huo, Tao Hong
Peking University First Hospital
OBJECTIVES The optimal duration of dual antiplatelet therapy
(DAPT) after percutaneous coronary intervention (PCI) remains
controversial. The present study sought to elucidate the frequency
and predictors of DAPT beyond 12 months after stent deployment in
Chinese population.
METHODS We examined the incidence of extended DAPT at 12
months follow-up among patients after successful PCI enrolled in a
28-site Chinese registry. Predictors of prolonged DAPT beyond 12
months were evaluated using multivariable cox proportional hazards
model.
RESULTS Among 2,130 patients, DAPT was continued in 46% (n¼983)
beyond 12 months after stent implantation. There was a signiﬁcant
heterogeneity of DAPT duration among centers. Compared to those
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with DAPT > 12 months were older, more often had history of hy-
pertension, diabetes and chronic kidney disease and were more likely
to have presented with non-ST-elevated myocardial infarction and
left ventricular dysfunction, treated with more drug-eluting stents
(DES) with longer stent length and stent size. In multivariable models,
variation of centers, age (risk ratio [RR] 1.01, 95% conﬁdence interval
[CI] 1.00 to 1.02, p<0.001), history of chronic kidney disease (RR1.73,
95%CI 1.02 to 2.95, p¼0.042) and numbers of DES implantation per
patient (RR1.14, 95%CI1.02 to 1.28, p¼0.021) were independent pre-
dictors of extended DAPT beyond 12 months.
CONCLUSIONS Almost half of patients after stent deployment
continued DAPT beyond 12 months. Prolonged DAPT was associated
with a high incidence of comorbidities and complex intervention as
well as signiﬁcant region variation.
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A Long Noncoding RNA, AC100865.1, Regulates CAD by Targeting
miR-205-5P
Yue Cai, Chunyu Zeng
Department of Cardiology, Daping Hospital, The Third Military Medical
University, Chongqing, P.R. China
OBJECTIVES Coronary artery diseases (CAD) is one of the most
common and serious cardiovascular diseases. Studies have shown
that lncRNA closely associated with a number of human diseases,
including CAD. However, the potential functional role of lncRNAs in
CAD remains unclear. We identiﬁed LncRNA-AC100865.1(LncRNA-
CAD) and miR-205-5p. Here, we tested the hypothesis that LncRNA-
CAD and miR-205-5p can participate in the regulation of CAD in vivo
and in vitro.
METHODS A microarray was performed to discovery LncRNA-CAD
and miR-205-5p. Then, a real-time ﬂuorescence quantitative PCR was
used to verify this results. Luciferase reporter was performed to verify
the direct binding site for LncRNA-CAD and miR-205-5p.
RESULTS According to microarray and Q-PCR, compared with con-
trols, LncRNA-CAD and miR-205-5p were signiﬁcantly upregulated in
the plasma of patients with AS. The results from loss and gain func-
tion of LncRNA-CAD indicated that LncRNA-CAD could promote the
expression of miR-205-5p. And PTEN was identiﬁed as a miR-205-5p
target gene to mediate the function of miR-205-5p in AS. By knock-
down the expression of PTEN in HUVECs, it showed enhanced
inﬂammation responses. Further, we investigated the molecular
mechanism by which LncRNA-CAD expression is regulated, Bioinfor-
matics analysis was performed to ﬁnd LncRNA-CAD and miR-205-5p
have potential binding sites and conﬁrmed through luciferase re-
porter, and found that LncRNA-CAD could directly bind to the pro-
moter of miR-205-5p, and regulate the expression of PTEN in the CAD.
CONCLUSIONS Our study reveals a novel CAD regulating model
which is composed of LncRNA-CAD, miR-205-5p and PTEN. Modula-
tion of their levels may provide a new approach for tackling CAD.
GW26-e0269
Incidence Predictors Of Discontinued Dual Antiplatelet Therapy Among
Patients After Percutaneous Coronary Intervention
Jie Jiang, Bo Zheng, Yan Zhang, Ronghui Yu, Yong Huo, Tao Hong
Peking University First Hospital
OBJECTIVES Dual antiplatelet therapy (DAPT) cessation increases the
risk of adverse events after percutaneous coronary intervention (PCI).
The present study sought to elucidate the frequency and predictors of
discontinued DAPT (duration shorter than 6 months) after stent
deployment in Chinese population.
METHODS We examined the incidence of discontinued DAPT within 6
months among patients after successful PCI enrolled in a 28-site
Chinese registry. Predictors of prolonged DAPT beyond 12 months
were evaluated using multivariable cox proportional hazards model.
RESULTS Among 3,102 patients, DAPT cessation was in 6.9% (n¼214)
within 6 months after PCI procedure. There was a signiﬁcant hetero-
geneity of DAPT duration among centers. Compared to those without
DAPT discontinuation (duration  6 months), patients with DAPT
discontinued were older, less often had history of hyperlipidemia, and
were more likely to have presented with higher incidence of left
ventricular dysfunction and lower hemoglobin level, underwent
more emergent PCI procedure with increasing number of longerdrug-eluting stents (DES). In multivariable models, variation of cen-
ters, history of dyslipidemia (RR 0.68, 95%CI 0.50 to 0.93, p¼0.014),
hemoglobin level (RR 0.98, 95%CI 0.97 to 0.99, p<0.001) and total
amounts of DES deployment (RR0.64, 95%CI 0.54 to 0.76, p<0.001)
were independent predictors of DAPT cessation< 6 months.
CONCLUSIONS Only less than 7% of patients discontinued DAPT
within 6 months after stent deployment. DAPT cessation was associ-
ated with signiﬁcant region variation, low incidence of comorbidities
and less complex intervention.
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The Relationship between Urokinase-type Plasminogen Activator and Its
Receptor and the Stenosis of the Coronary Artery in Patients with Coronary
Heart Disease
Zhenda Zheng, Cailian Cheng, Lin Wu, Dinghui Liu, Zhiming Song,
Lin Chen, Xiaoxian Qian
The Third Afﬁliated Hospital, SUN Yat-sen University, Guangzhou
510630, China
OBJECTIVES We investigated the change of u-PA and its receptor in
different types of the CHD. With the results of coronary artery angi-
ography, we discussed the relationship between the results of coro-
nary artery angiography and the levels of u-PA, u-PAR, to uncover the
clinic role of u-PA, u-PAR in the patients with coronary heart disease.
METHODS We divide all the cases into 4 groups: 30 cases in NCAD
group, 20 patients in SA group, 25 patients in UA group, 30 patients in
AMI group. In all these groups, we measured the expression of u-PAR
on neutrophile with ﬂow cytometry and measured the levels of u-PA
in plasma with a solid phase enzyme-linked immuneosorbent assay
(ELISA) and analysis the relationship between the results of coronary
artery angiography and the levels of u-PA, u-PAR.
RESULTS All the samples taken from the coronary artery in this 4
groups were analyzed. The difference between the expression levels
of u-PAR on neutrophile and the plasma levels of u-PA was signiﬁcant,
the AMI group were higher than the UA group[(69.075.92)%
vs.(51.053.15)%, (0.810.11) mg/L vs. (0.500.05) mg/L, P<0.001];
the UA group were higher than the SA group[(51.053.15% vs.
(30.374.77)%, (0.500.05) mg/L vs. (0.360.04) mg/L,P<0.001]; but
the different between the SA group and the NCAD group was not
signiﬁcant[(30.374.77)% vs. (30.024.65)%, (0.360.04) mg/L vs.
(0.300.03) mg/L, P>0.05]. Compared the samples taken from the
peripheral vessel with the samples taken from the coronary artery, the
difference between the plasma levels of u-PA and the expression
levels of u-PAR on neutrophile was not signiﬁcant (0.0030.002,
P>0.05; -0.120.099, P>0.05). In the samples taken from the coronary
artery, the plasma levels of u-PA and the expression of u-PAR on
neutrophile were all signiﬁcantly related to Jenkins score (r1¼0.943,
P<0.001; r2¼0.814, P<0.001).
CONCLUSIONS We may predict the severity of the pathological
change of the coronary artery through measured the levels of u-PA in
the plasma or the expressions of u-PAR in neutrophile which taken
from the peripheral vessel.
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Serum bone morphogenetic proteins can predict the coronary artery
calciﬁcation in the elderly
Long Peng,1 Xixiang Tang,2 Junlin Zhong,3 Jinlai Liu1
1Department of Cardiology, The Third Afﬁliated Hospital, Sun Yat-sen
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sen University; 3Department of Ultrasound, the Third Afﬁliated
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OBJECTIVES Coronary artery calciﬁcation (CAC) is associated with
greater risk of mortality in elderly individuals. Basic researches have
indicated that bone morphogenetic proteins (BMPs) might activate
coronary artery smooth muscle cell calciﬁcation. However, the pre-
dictive values of serum BMPs for the progression of CAC remain un-
certain. We aimed to assess the values of serum BMP-2, BMP-4 and
BMP-7 for predicting the CAC in the elderly.
METHODS The present study was performed in 573 subjects  65y
undergoing 64 or 320-slice coronary computed tomography angiog-
raphy (CCTA). CAC was evaluated by the Agatston calcium score
determined by CCTA. Serum levels of BMP-2, BMP-4 and BMP-7 were
measured using the appropriate ELISA kits. Correlations between CAC
and BMPs were assessed by Pearson correlation analysis. Multivariate
